Filed: 8/14/2024ACC: 0001839435-24-000005
📋 What this filing means
OCTAGON CAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 44 equity positions with a total reported market value of $636.28M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
44
Positions
$636.28M
Total AUM (reported)
90.86M
Total Shares
Allocation by class
COM$384.44M60.4%
SPONSORED ADS$93.35M14.7%
COM NEW$80.15M12.6%
COM PAR $.01$60.31M9.5%
COM SHS$10.24M1.6%
ADS$3.34M0.5%
CL A ORD SHS$2.56M0.4%
Portfolio Concentration
Top 3$229.45M36.1%
4–10$208.03M32.7%
11–25$147.29M23.1%
Rest$51.50M8.1%
Top 3 weight
36.1%
Top 10 weight
68.8%
Voting Authority Distribution
Total shares with voting rights: 90.26M
Sole
Full voting authority
90.26M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole44
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings44
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares3.23M
TypeSH
Market value$123.94M
19.48%
Sole
2.88M
Shared
0.00
None
0.00
INSMED INC
SOLEShares900.22K
TypeSH
Market value$60.31M
9.48%
Sole
650.22K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.75M
TypeSH
Market value$45.20M
7.10%
Sole
1.75M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$44.77M
7.04%
Sole
1.14M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares1.18M
TypeSH
Market value$41.67M
6.55%
Sole
1.18M
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares1.80M
TypeSH
Market value$33.45M
5.26%
Sole
1.80M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares1.90M
TypeSH
Market value$27.40M
4.31%
Sole
1.90M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares488K
TypeSH
Market value$22.08M
3.47%
Sole
488K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.35M
TypeSH
Market value$21.18M
3.33%
Sole
2.35M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares690K
TypeSH
Market value$17.48M
2.75%
Sole
690K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares2.42M
TypeSH
Market value$16.59M
2.61%
Sole
2.42M
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares1.58M
TypeSH
Market value$15.76M
2.48%
Sole
1.58M
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares2.15M
TypeSH
Market value$15.52M
2.44%
Sole
2.15M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares260K
TypeSH
Market value$10.75M
1.69%
Sole
260K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares4.57M
TypeSH
Market value$10.24M
1.61%
Sole
4.57M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$9.51M
1.50%
Sole
1.09M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.36M
TypeSH
Market value$9.29M
1.46%
Sole
1.36M
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares9.19M
TypeSH
Market value$8.28M
1.30%
Sole
9.19M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares620K
TypeSH
Market value$8.07M
1.27%
Sole
620K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares2.58M
TypeSH
Market value$7.99M
1.26%
Sole
2.58M
Shared
0.00
None
0.00
REGULUS THERAPEUTICS INC
SOLEShares4.26M
TypeSH
Market value$7.61M
1.20%
Sole
4.26M
Shared
0.00
None
0.00
ALLOVIR INC
SOLEShares9.80M
TypeSH
Market value$7.09M
1.11%
Sole
9.80M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares600K
TypeSH
Market value$7.02M
1.10%
Sole
600K
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares3.22M
TypeSH
Market value$6.92M
1.09%
Sole
3.22M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares283.37K
TypeSH
Market value$6.65M
1.04%
Sole
283.37K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 3.23M | SH | $123.94M 19.48% | 2.88M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 900.22K | SH | $60.31M 9.48% | 650.22K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1.75M | SH | $45.20M 7.10% | 1.75M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 1.14M | SH | $44.77M 7.04% | 1.14M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 1.18M | SH | $41.67M 6.55% | 1.18M | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 1.80M | SH | $33.45M 5.26% | 1.80M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 1.90M | SH | $27.40M 4.31% | 1.90M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 488K | SH | $22.08M 3.47% | 488K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 2.35M | SH | $21.18M 3.33% | 2.35M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 690K | SH | $17.48M 2.75% | 690K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 2.42M | SH | $16.59M 2.61% | 2.42M | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 1.58M | SH | $15.76M 2.48% | 1.58M | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 2.15M | SH | $15.52M 2.44% | 2.15M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 260K | SH | $10.75M 1.69% | 260K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 4.57M | SH | $10.24M 1.61% | 4.57M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.09M | SH | $9.51M 1.50% | 1.09M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.36M | SH | $9.29M 1.46% | 1.36M | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 9.19M | SH | $8.28M 1.30% | 9.19M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 620K | SH | $8.07M 1.27% | 620K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 2.58M | SH | $7.99M 1.26% | 2.58M | 0.00 | 0.00 |
REGULUS THERAPEUTICS INCSOLE | COM | 4.26M | SH | $7.61M 1.20% | 4.26M | 0.00 | 0.00 |
ALLOVIR INCSOLE | COM | 9.80M | SH | $7.09M 1.11% | 9.80M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 600K | SH | $7.02M 1.10% | 600K | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 3.22M | SH | $6.92M 1.09% | 3.22M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 283.37K | SH | $6.65M 1.04% | 283.37K | 0.00 | 0.00 |
Page 1 of 2